Factors affecting membrane-controlled drug release for an osmotic pump tablet (OPT) utilizing (SBE)7m-β-CD as both a solubilizer and osmotic agent
- 27 July 1999
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 60 (2-3) , 311-319
- https://doi.org/10.1016/s0168-3659(99)00077-2
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Release of testosterone from an osmotic pump tablet utilizing (SBE)7m-β-cyclodextrin as both a solubilizing and an osmotic pump agentJournal of Controlled Release, 1999
- Design and Evaluation of an Osmotic Pump Tablet (OPT) for Chlorpromazine Using (SBE)7m-β-CDPharmaceutical Research, 1999
- Design and Evaluation of an Osmotic Pump Tablet (OPT) for Prednisolone, a Poorly Water Soluble Drug, Using (SBE)7m-β-CDPharmaceutical Research, 1998
- Controlled porosity solubility- and resin-modulated osmotic drug delivery systems for release of diltiazem hydrochlorideJournal of Controlled Release, 1991
- The Solubility-Modulated Osmotic Pump: In Vitro/in Vivo Release of Diltiazem HydrochloridePharmaceutical Research, 1991
- Use of Modified Ethylcellulose Lattices for Microporous Coating of Osmotic TabletsPharmaceutical Research, 1991
- Theophylline Tablets Coated with Aqueous Latexes Containing Dispersed Pore FormersJournal of Pharmaceutical Sciences, 1990
- Mechanism of water transport in controlled porosity osmotic devicesJournal of Membrane Science, 1989
- Osmotic flow through controlled porosity films: An approach to delivery of water soluble compoundsJournal of Controlled Release, 1985
- The permeability of enteric coatings and the dissolution rates of coated tabletsJournal of Pharmacy and Pharmacology, 1982